Kansai™ Pharmaceutical Industries® Co., Ltd

Kansai™ Pharmaceutical Industries® Co., Ltd: Leveraging Japanese Pharma 4.0 Technology Transfer for Better Access to Health Care! Japan is the third largest pharmaceutical market in the world Estimated to $108.08 Billion by 2025 with a CAGR of 7.17% and a critical export market for U.S. pharmaceuticals. Since 2013, the Government of Japan (“GOJ”) has promoted the healthcare industry as an important growth engine under the country’s economic revitalization and growth strategy. Japan’s healthcare field, including the pharmaceuticals sector, has recently experienced renewed attention. Pharmaceutical industries continue to face challenges of globalization, complex supply chains and hyper-competition - all while demand for treatments continues to increase. As a result, the need for greater throughput, higher quality and reduced costs has become a top priority. Successful implementation of Lean in Toyota, inspired a lot of organizations around the world to start their journey towards Lean Management. Increased efficiency, improved productivity and reduced waste are some major benefits of Lean implementation. However, you can’t deny the fact that after Lean implementation many organizations have shown improvement in overall business performance. It has led to an improvement in quality, elimination of waste and reduction in costs. Better use of assets, flow optimization, greater flexibility, and a sustainable and consistent improvement strategy are some of the key areas that the industry needs to focus on. By eliminating waste, prioritizing the customer and flow focus, the healthcare industry is expected to grow at a very fast pace in the foreseeable future. According to various studies and surveys, Pharma companies who have successfully implemented Lean initiatives are seen to grow at a higher CAGR and by embracing such initiatives they realized millions of benefits.